ImportRefusal LogoImportRefusal

Windlas Healthcare Private Limited

⚠️ Moderate Risk

FEI: 3005339091 • Dehradun, Uttaranchal • INDIA

FEI

FEI Number

3005339091

📍

Location

Dehradun, Uttaranchal

🇮🇳

Country

INDIA
🏢

Address

Plot No 183 & 192 Mohabewala Industrial, , Dehradun, Uttaranchal, India

Moderate Risk

FDA Import Risk Assessment

46.4
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
3
Unique Violations
2/9/2023
Latest Refusal
1/5/2007
Earliest Refusal

Score Breakdown

Violation Severity
80.0×40%
Refusal Volume
28.8×30%
Recency
27.1×20%
Frequency
3.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

273×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
2/9/2023
61PDY26METFORMIN (ANTI-DIABETIC)
118NOT LISTED
27DRUG GMPS
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/18/2022
62OCY12VALSARTAN (ANTI-HYPERTENSIVE - PART II)
27DRUG GMPS
Division of Northern Border Imports (DNBI)
6/25/2021
61EDA09MONTELUKAST SODIUM (ANTI-ASTHMATIC)
27DRUG GMPS
Division of Southeast Imports (DSEI)
1/5/2007
61GDK85OFLOXACIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
75UNAPPROVED
New York District Office (NYK-DO)
1/5/2007
60XCK02METOPROLOL (ANTI-ADRENERGIC)
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is Windlas Healthcare Private Limited's FDA import refusal history?

Windlas Healthcare Private Limited (FEI: 3005339091) has 5 FDA import refusal record(s) in our database, spanning from 1/5/2007 to 2/9/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Windlas Healthcare Private Limited's FEI number is 3005339091.

What types of violations has Windlas Healthcare Private Limited received?

Windlas Healthcare Private Limited has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Windlas Healthcare Private Limited come from?

All FDA import refusal data for Windlas Healthcare Private Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.